We have previously shown that poly a$-( N-2-hydroxyethyl)-D,L-aspartamide is captured by rat visceral yolk sacs cultured in vitro by pinocytosis and also that substitution of the parent polymer with tyramine residues (19.2molX) caused a marked increase in its rate of capture. In this study we have investigated this phenomenon further by synthesizing a series of polyaspartamides with a range of tyramine contents (1.2, 4.9, 10.4, 16.9 and 21.9 mol%) and studying the relationship between their tyramine content and their rates of pinocytosis by rat visceral yolk sacs cultured in uitro. Using samples of narrow polydispersity we examined the effect of molecular weight on rate of capture. The effect of serum proteins and substrate concentration on the rate of polymer capture was also investigated.
We have previously shown that poly a$-( N-2-hydroxyethyl)-D,L-aspartamide is captured by rat visceral yolk sacs cultured in vitro by pinocytosis and also that substitution of the parent polymer with tyramine residues (19.2molX) caused a marked increase in its rate of capture. In this study we have investigated this phenomenon further by synthesizing a series of polyaspartamides with a range of tyramine contents (1.2, 4.9, 10.4, 16.9 and 21.9 mol%) and studying the relationship between their tyramine content and their rates of pinocytosis by rat visceral yolk sacs cultured in uitro. Using samples of narrow polydispersity we examined the effect of molecular weight on rate of capture. The effect of serum proteins and substrate concentration on the rate of polymer capture was also investigated.
The polyaspartamide derivatives were prepared as previously described (VlsPk et al., 1979; Drobnik et al., 1979) and radiolabelled with lz5I using the chloramine-T method . The resultant 1251-labelled preparations were stable during both storage and incubation. To quantify their rates of capture by rat visceral yolk sacs, 1251-labelled polymers were incubated with the tissue in serum-free medium 199 and uptake measured as described previously (Ibbotson & Williams, 1979) . It was found that pinocytic capture of the radiolabelled polymers was linear with time over a 5 h incubation period and that the rate of uptake of polyaspartamide increased with increasing tyramine content. Above a tyramine content of 10mol% the rate of uptake of polymer increased dramatically and linearly with rising tyramine content of the polymer (up to 21.9mol%). The effect of increasing tyramine content on the pinocytic uptake of polyaspartamide derivatives was very similar to that already described for tyrosinamidecontaining N-2-hydroxypropyl methacrylamide copolymers (Duncan et al., 1984) .
The molecular weight of synthetic polymers has been shown previously to influence their rate of pinocytosis by yolk sacs in vitro Cartlidge et al., 1982) . Three samples were chosen for this study, each containing 4.9molx tyramine, but of M , 8000, 39000 and 60000. Uptake by yolk sacs was measured over a 3 h incubation period and all three samples were captured at the same rate. Therefore over the molecular weight range studied, polymer size has no effect on rate of capture.
The presence of calf serum (10-50%) in the incubation medium severely inhibited capture of all polyaspartamide derivatives. Although this effect was partially attributable to the inhibition of pinocytic vesicle formation in the yolk sac by serum (Forster & Williams, 1984) , competition by serum proteins with polyaspartamide molecules for cellsurface binding sites was largely responsible for the decrease in the rate of polymer capture observed. As the serum proteins can effectively compete with the polymeric substrate, the polymer-membrane interaction is likely to be very non-specific.
The effect of substrate concentration (5-100jig/ml) on the uptake of the derivatives containing the least (1.2mol%) and the most (21.9molX) tyramine was examined. In this experiment a trace amount of radiolabelled polymer was added to the incubation in addition to the appropriate concentration of non-radioactively labelled polymer. Whereas increasing substrate concentration had no effect on the rate of uptake (measured in pl/mg of protein per h) of the former, it caused a progressive decrease in the rate of capture of the latter. These data indicate that over the substrate concentration range studied the polymer with low tyramine content is captured by fluid-phase pinocytosis whereas the more highly substituted polymer is captured by adsorptive pinocytosis. The attachment of chemotherapeutic agents to soluble macromolecules restricts cellular uptake to endocytosis, thus preventing indiscriminate penetration into cells. Such conjugation affords both retention within the bloodstream and also the possibility to target the drug-carrier complex to specific cell types (Duncan & KopeEek, 1984) . The ideal drug carrier would have a molecular weight sufficiently high to prevent rapid loss by glomerular filtration and sufficiently low to permit endocytic capture by cell types other than phagocytes. Also, following drug delivery, the carrier should 608th MEETING, KEELE be eliminated from the body in order to prevent adverse reactions due to excessive polymer accumulation within lysosomes. It has been proposed (KopeEek et al., 1981) that this latter requirement can be met by cross-linking polymer chains, of molecular weight sufficiently low to allow passage through the kidney glomerulus, with oligopeptide sequences. The cross-linked polymer is too large to cross the glomerular filter but, following pinocytosis and exposure to the lysosomal enzymes, the lower molecular weight chains are liberated, and are excreted in the urine (KopeEek et al.,  1981) . The aim of the present investigation was to study the effect of molecular weight on blood clearance and body distribution after intravenous administration. The possibility of targeting cross-linked copolymers to liver by incorporation of galactosamine was also investigated. A copolymer of HPMA whose chains were cross-linked by the sequence Gly-Gly-Phe-Tyr-HMDA-Tyr-Phe-GlyGly (KopeEek et al., 198 1) was fractionated using Sepharose 6B to give five samples of different mean molecular weights (m, 34000, 110000, 155000,400000 and >400000); these were then radiolabelled with [12sI]iodide. Male Wistar rats of 200-25Og body weight were injected intravenously with the radiolabelled fractions, blood samples taken at intervals up to 1 h and assayed for radioactivity. After 1 h the lungs, liver, kidneys and spleen were removed, homogenized in distilled water and their content of radioactivity measured. Clearance from the bloodstream was more rapid with copolymers of lower molecular weight, presumably because these fractions passed into the glomerular filtrate. The distribution of radioactivity recovered from the tissues and blood after 1 h showed that in all cases most of the radioactivity remained in the circulation. The unfractionated copolymer and the copolymer of M, 34000 were present in the kidney in higher amcunts (3.14% and 7.51% respectively) than were the higher M, fractions (0.62-1 32%). With all the copolymer samples, little radioactivity was recovered in the liver after 1 h (2.55.13%), and the individual values were' not related to M,. The spleen and lung rarely contained more than 1% of the total radioactivity recovered. The results of both blood clearance and body distribution support the previous finding that HPMA copolymers are taken up relatively slowly by cells by fluid-phase pinocytosis (Duncan et al., 1981 ; Cartlidge et al., 1982) .
Targeting of cross-linked HPMA copolymers to the liver was achieved by making use of the hepatocyte receptor for galactose-terminating glycoproteins. The incorporation of diglycyl-Dgalactosamine side-chains into an unfractionated cross-linked copolymer yielded a product that showed rapid blood clearance as compared with a similar copolymer that did not contain the carbohydrate residue. Administration of the copolymer containing galactosamine residues was followed by a high concentration of radioactivity in the liver after l h (62.85% of the radioactivity recovered), as compared with the unmodified product (5.86% in the liver after 1 h). This observation is presumably attributable to receptor-mediated pinocytic capture of the galactosaminecontaining copolymer by hepatocytes.
There is much indirect evidence to support a primary role for intracellular Ca2+ in the regulation of pancreatic enzyme secretion (Case, 1978; Petersen, 1982) . It has recently been demonstrated directly, that stimulation of isolated pancreatic acini by physiological secretagogues is accompanied by a transient rise in the cytosolic free Caz+ concentration (Dormer, 1983; Ochs et al., 1983) . In order to show that this increase in free Caz+ causes the stimulation of secretion it is necessary to demonstrate that inhibiting the Ca2+ rise blocks secretion. The method of hypotonic swelling used to introduce the Ca2+-activated photoprotein aequorin into intact acinar cells (Dormer, 1983 ) also allows other impermeant molecules to be incorporated. In the present study a Ca*+-chelator, EGTA, has been incorporated into intact acinar cells by hypotonic swelling and its effects on amylase release measured.
Isolated rat pancreatic acini were prepared as described previously (Williams et al., 1978; Dormer, 1983) . EGTA was incorporated by a modification of the hypotonic swelling method (Dormer, 1983) . Swelling was induced by adding lomM-Tes, pH 7.4, containing 1OmM-ATP and 
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1OmM-EGTA to a pellet of acini (approx. 2 x 10' acini) for 30s at 37°C. The isotonicity was then restored and incubation continued for 30min at 37°C. Acini were then Table 1 . Effects of intracellular EGTA on carbamylcholinestimulated amylase release Rat pancreatic acini were incubated for 30min in Hepesbuffered Ringer solution containing 10mM-EGTA (unswollen) or for 30s in hypotonic medium containing 10mM-EGTA followed by 30min in the same medium restored to isotonicity (swollen). Amylase release was measured after a further 30min in Hepes-buffered Ringer solution containing 1.3 rnM-CaC1,. Responses of EGTAtreated acini are expressed as the percentage inhibition of the response to carbamylcholine of untreated acini. Results are meam ~s . E . M .
for the number of determinations shown in parentheses. 
